Both medications may cause gastrointestinal side effects, requiring careful monitoring and potential dose adjustments
Our results are consistent with a post hoc analysis of the EXCEL trial [29] which concluded that exenatide combined with SGLT-2i reduced the risk of MACE (defined as cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) compared with exenatide monotherapy and also improved eGFR significantly
Diabetes Care 35:252258 Knudsen LB, Nielsen PF, Huusfeldt PO et al (2000) Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration
The effects of the oral supplementation of L-Cystine associated with reduced L-Glutathione-GSH on human skin pigmentation: a randomized, double-blinded, benchmark- and placebo-controlled clinical trial
These new treatment possibilities for clinicians, coupled with an increase in industry marketing and patients personal needs, have led to an explosion of prescriptions for these drugs especially in Western countries [9]